BIOGEN INC. Cash & Short-Term Investments 2006-2026 | BIIB
Beta
What is BIOGEN INC.'s current cash & short-term investments?
BIOGEN INC. (BIIB) annual cash & short-term investments for 2025 was $3.82B, a 60.66% increase from 2024. BIOGEN INC. cash & short-term investments for the quarter ending March 31, 2026 was $4.28B.
What was BIOGEN INC.'s cash & short-term investments in 2024?
BIOGEN INC. annual cash & short-term investments for 2024 was $2.38B, a 126.21% increase from 2023.
What was BIOGEN INC.'s cash & short-term investments in 2023?
BIOGEN INC. annual cash & short-term investments for 2023 was $1.05B, a 78.54% decline from 2022.
What is BIOGEN INC.'s 5-year cash & short-term investments CAGR?
BIOGEN INC. cash & short-term investments grew at a compound annual growth rate (CAGR) of 7.89% from FY2020 to FY2025, going from $2.61B to $3.82B over 5 years.
Cash & Short-Term Investments History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+7.9%
FY2020
$2.61B
→
FY2025
$3.82B
0607080910111213141516171819202122232425
5 years selected
Cash & Short-Term Investments History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $3.82B | +60.7% | 10-K |
| FY2024 | $2.38B | +126.2% | 10-K |
| FY2023 | $1.05B | -78.5% | 10-K |
| FY2022 | $4.89B | +28.7% | 10-K |
| FY2021 | $3.80B | +45.7% | 10-K |
| FY2020 | $2.61B | -41.7% | 10-K |
| FY2019 | $4.48B | +26.5% | 10-K |
| FY2018 | $3.54B | -4.1% | 10-K |
| FY2017 | $3.69B | -24.6% | 10-K |
| FY2016 | $4.90B | +42.8% | 10-K |
| FY2015 | $3.43B | +85.8% | 10-K |
| FY2014 | $1.85B | +50.9% | 10-K |
| FY2013 | $1.22B | -28.3% | 10-K |
| FY2012 | $1.71B | +0.9% | 10-K |
| FY2011 | $1.69B | +40.0% | 10-K |
| FY2010 | $1.21B | -4.4% | 10-K |
| FY2009 | $1.26B | -5.8% | 10-K |
| FY2008 | $1.34B | +103.4% | 10-K |
| FY2007 | $659.7M | -0.3% | 10-K |
| FY2006 | $661.4M | - | 10-K |
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →